Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Credit agrmnt [a]
IsoPlexis Corp (ISO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2023 8-K Quarterly results
03/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/09/2023 8-K Other Events  Interactive Data
01/12/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "IsoPlexis Reports Preliminary Full Year 2022 Revenue"
12/21/2022 8-K Investor presentation
Docs: "AGREEMENT AND PLAN OF MERGER",
"VOTING AGREEMENT",
"VOTING AGREEMENT",
"Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company",
"INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT BERKELEY LIGHTS, ISOPLEXIS AND THE PROPOSED TRANSACTION.",
"INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY"
09/12/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "2022 EMPOWERING LABS, CHANGING HUMAN HEALTH"
08/23/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/11/2022 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "IsoPlexis Reports Preliminary First Quarter 2022 Revenue, Streamlines Operating Structure to Support Sustainable Growth Reiterates full year guidance and extends cash runway to H2 2024"
03/02/2022 8-K Quarterly results
02/02/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "IsoPlexis Reports Preliminary Full Year 2021 Revenue, Releases Industry-First Superhuman Cell Library Superhero cells are key to the efficacy, potency, and durability of therapies across the human health spectrum",
"5 FUNCTIONAL PROTEOMICS SINGLE-CELL BIOLOGY SINGLE-CELL MULTI-OMICS GAP GAP"
12/10/2021 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "IsoPlexis Reports Third Quarter 2021 Financial Results Year-to-date 2021 revenue increased 68% over prior year period"
11/01/2021 8-K Credit agreement amendment
Docs: "Second Amendment to Credit Agreement and Guaranty, by and among IsoPlexis Corporation, the Lenders party thereto and Perceptive Credit Holdings III, LP, as a lender and administrative agent"
10/13/2021 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Departure of Directors or C...
Docs: "Underwriting Agreement, by and among IsoPlexis Corporation and Morgan Stanley & Co. LLC, Cowen and Company, LLC, Evercore Group, L.L.C. and SVB Leerink LLC, as representatives of the several underwriters specified therein",
"Eighth Amended and Restated Certificate of Incorporation of IsoPlexis Corporation",
"Amended and Restated By-laws of IsoPlexis Corporation",
"Offer Letter, by and between IsoPlexis Corporation and Richard W. Rew II",
"IsoPlexis Announces Closing of Public Offering"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy